dMMR
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
dMMR
Jul 10, 2024, 12:49 |
Blog
Erman Akkus: May immune-inflammation stimulation by vaccines interact with MSI-H status?
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X: “We…
Jul 6, 2024, 07:58 |
Drugs
Tanja Obradovic: Important lesson in development of the PDL-1 inhibitor just came in
Tanja Obradovic posted on LinkedIn: "Important lesson in the development of the PDL-1 inhibitor just…
Jun 30, 2024, 14:51 |
Insight
Sergio Cifuentes: Phase 2 study on neoadjuvant nivolumab + ipilimumab in dMMR colon cancer
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, shared a post on X about…
Jun 8, 2024, 02:16 |
Blog
Toni Choueiri: NICHE-2 by Myriam Chalabi published in NEJM
Toni Choueiri shared a post on X: , "NICHE-2 published…
May 5, 2024, 07:19 |
Blog
Elias Chandran: Our meta-analysis of dMMR and MSI-H in UC
Elias Chandran, Medical Oncologist at National Cancer Institute shared on X: “Excited to share our…
Apr 14, 2024, 11:39 |
Drugs
Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X/Twitter: "FDA…
All:
6
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube